Assessment of Risks and Benefits of Beta Cell Replacement Versus Automated Insulin Delivery Systems for Type 1 Diabetes.

Added 624 days ago (01.09.2020)

Authors: Senior P, Lam A, Farnsworth K, Perkins B, Rabasa-Lhoret R